Public annual accounts

EVOLOGIC financials

A multi-period view of the public annual-account figures reported for EVOLOGIC, with comparable measures and links to available source documents.

Company overview
Registry number

0862919621

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€110,950

+52%

EBITDA
€107,766

+55.7%

Total assets
€230,904

-21.5%

Equity
€127,497

-34.5%

EBITDA margin +97.1% · Equity ratio +55.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€110,950€107,766€230,904€127,497-
202431 Dec 2024€72,974€69,209€294,328€194,625-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report